STERIS plc provided earnings guidance for the fiscal 2023. For the year, constant currency organic revenue growth is anticipated to be approximately 11%. As reported revenue is expected to increase approximately 12%, reflecting the net impact of acquisitions and divestitures as well as the anticipated negative impact of foreign currency fluctuations.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
230.6 USD | 0.00% | -2.06% | +4.89% |
05-20 | Steris Insider Sold Shares Worth $267,313, According to a Recent SEC Filing | MT |
05-17 | Steris Insider Sold Shares Worth $7,532,366, According to a Recent SEC Filing | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.89% | 22.79B | |
-4.77% | 182B | |
+4.10% | 114B | |
-3.85% | 67.76B | |
+5.19% | 51.91B | |
+5.54% | 43.23B | |
+6.07% | 41.07B | |
+23.81% | 32.07B | |
+15.86% | 25B | |
-5.06% | 24.35B |
- Stock Market
- Equities
- STE Stock
- News STERIS plc
- STERIS plc Provides Earnings Guidance for Fiscal 2023